ArticleClinical Medicine Insights. Oncology2012

Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumab.

Allan Lipton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.